| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Molecular Immunology, Immunex Corporation, Seattle WA 98101
Oral administration of soluble protein Ag induces tolerance, a
phenomenon that has hampered mucosal vaccine design. To provoke active
immunity, orally administered Ag must be fed together with a mucosal
adjuvant such as cholera toxin (CT). Unfortunately, CT is not suitable
for clinical use because of its associated toxicity. There is,
therefore, a need to develop alternative mucosal immunization regimens.
Here we have attempted to alter the intrinsically tolerogenic nature of
the intestine and improve immunization potential by expanding and
activating intestinal APC in vivo. Previous studies have indicated that
intestinal dendritic cells (DC) present oral Ag, but do so in a
tolerogenic manner. In the present study we investigated whether DC can
be converted from tolerogenic into immunogenic APC by treating mice
with Flt3 ligand (Flt3L), a DC growth factor, and then immunizing with
CT. We observed increased local and systemic responses to CT in the
presence of elevated numbers of intestinal DC. In parallel, CT induced
up-regulation of CD80 and CD86 on these Flt3L-expanded DC. In an
attempt to develop a toxin-free adjuvant system, we investigated
whether IL-1 could be used as an alternative DC-activating stimulus.
Using a combination of Flt3L and IL-1
, we observed a potent active
response to fed soluble Ag, rather than the tolerogenic response
normally observed. These data suggest that Flt3L-expanded DC are well
positioned to regulate intestinal responses depending on the presence
or the absence of inflammatory signals. Flt3L may therefore be a
reagent useful for the design of mucosal immunization
strategies.
This article has been cited by other articles:
|
|
 |
|
  M Shale and S Ghosh How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease Gut, September 1, 2009; 58(9): 1291 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sekine, K. Kataoka, Y. Fukuyama, Y. Adachi, J. Davydova, M. Yamamoto, R. Kobayashi, K. Fujihashi, H. Suzuki, D. T. Curiel, et al. A Novel Adenovirus Expressing Flt3 Ligand Enhances Mucosal Immunity by Inducing Mature Nasopharyngeal-Associated Lymphoreticular Tissue Dendritic Cell Migration J. Immunol., June 15, 2008; 180(12): 8126 - 8134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Blazquez and M. C. Berin Gastrointestinal Dendritic Cells Promote Th2 Skewing via OX40L J. Immunol., April 1, 2008; 180(7): 4441 - 4450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Grdic, L. Ekman, K. Schon, K. Lindgren, J. Mattsson, K.-E. Magnusson, P. Ricciardi-Castagnoli, and N. Lycke Splenic Marginal Zone Dendritic Cells Mediate the Cholera Toxin Adjuvant Effect: Dependence on the ADP-Ribosyltransferase Activity of the Holotoxin J. Immunol., October 15, 2005; 175(8): 5192 - 5202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Favre, F. Spertini, and B. Corthesy Secretory IgA Possesses Intrinsic Modulatory Properties Stimulating Mucosal and Systemic Immune Responses J. Immunol., September 1, 2005; 175(5): 2793 - 2800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Zinselmeyer, J. Dempster, A. M. Gurney, D. Wokosin, M. Miller, H. Ho, O. R. Millington, K. M. Smith, C. M. Rush, I. Parker, et al. In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance J. Exp. Med., June 6, 2005; 201(11): 1815 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Smith and C. Nagler-Anderson Preventing Intolerance: The Induction of Nonresponsiveness to Dietary and Microbial Antigens in the Intestinal Mucosa J. Immunol., April 1, 2005; 174(7): 3851 - 3857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Turnbull, U. Yrlid, C. D. Jenkins, and G. G. MacPherson Intestinal Dendritic Cell Subsets: Differential Effects of Systemic TLR4 Stimulation on Migratory Fate and Activation In Vivo J. Immunol., February 1, 2005; 174(3): 1374 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Teleshova, J. Jones, J. Kenney, J. Purcell, R. Bohm, A. Gettie, and M. Pope Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells J. Leukoc. Biol., June 1, 2004; 75(6): 1102 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Masten, G. K. Olson, D. F. Kusewitt, and M. F. Lipscomb Flt3 Ligand Preferentially Increases the Number of Functionally Active Myeloid Dendritic Cells in the Lungs of Mice J. Immunol., April 1, 2004; 172(7): 4077 - 4083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kataoka, J. R. McGhee, R. Kobayashi, K. Fujihashi, S. Shizukuishi, and K. Fujihashi Nasal Flt3 Ligand cDNA Elicits CD11c+CD8+ Dendritic Cells for Enhanced Mucosal Immunity J. Immunol., March 15, 2004; 172(6): 3612 - 3619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rey, N. Garin, F. Spertini, and B. Corthesy Targeting of Secretory IgA to Peyer's Patch Dendritic and T Cells after Transport by Intestinal M Cells J. Immunol., March 1, 2004; 172(5): 3026 - 3033. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis An Enzymatically Active A Domain Is Required for Cholera-Like Enterotoxins To Induce a Long-Lived Blockade on the Induction of Oral Tolerance: New Method for Screening Mucosal Adjuvants Infect. Immun., December 1, 2003; 71(12): 6850 - 6856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J Stagg, A L Hart, S C Knight, and M A Kamm The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria Gut, October 1, 2003; 52(10): 1522 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pabst, A. Luhrmann, I. Steinmetz, and T. Tschernig A Single Intratracheal Dose of the Growth Factor Fms-Like Tyrosine Kinase Receptor-3 Ligand Induces a Rapid Differential Increase of Dendritic Cells and Lymphocyte Subsets in Lung Tissue and Bronchoalveolar Lavage, Resulting in an Increased Local Antibody Production J. Immunol., July 1, 2003; 171(1): 325 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kato, K. Fujihashi, R. Kato, T. Dohi, K. Fujihashi, Y. Hagiwara, K. Kataoka, R. Kobayashi, and J. R. McGhee Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions Int. Immunol., February 1, 2003; 15(2): 145 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway J. Leukoc. Biol., November 1, 2002; 72(5): 962 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, T. R. Fouts, and G. K. Lewis Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway Infect. Immun., October 1, 2002; 70(10): 5533 - 5539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Williamson, J. M. Bilsborough, and J. L. Viney Regulation of Mucosal Dendritic Cell Function by Receptor Activator of NF-{kappa}B (RANK)/RANK Ligand Interactions: Impact on Tolerance Induction J. Immunol., October 1, 2002; 169(7): 3606 - 3612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Disis, K. Rinn, K. L. Knutson, D. Davis, D. Caron, C. dela Rosa, and K. Schiffman Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers Blood, April 15, 2002; 99(8): 2845 - 2850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Christensen, H. Frokiar, and J. J. Pestka Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells J. Immunol., January 1, 2002; 168(1): 171 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Etchart, P.-O. Desmoulins, K. Chemin, C. Maliszewski, B. Dubois, F. Wild, and D. Kaiserlian Dendritic Cells Recruitment and In Vivo Priming of CD8+ CTL Induced by a Single Topical or Transepithelial Immunization Via the Buccal Mucosa with Measles Virus Nucleoprotein J. Immunol., July 1, 2001; 167(1): 384 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. De Smedt, E. Butz, J. Smith, R. Maldonado-Lopez, B. Pajak, M. Moser, and C. Maliszewski CD8{alpha}- and CD8{alpha}+ subclasses of dendritic cells undergo phenotypic and functional maturation in vitro and in vivo J. Leukoc. Biol., June 1, 2001; 69(6): 951 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, I. Goldschneider, J. O’Rourke, and R. E. Cone Blood mononuclear cells induce regulatory NK T thymocytes in anterior chamber-associated immune deviation J. Leukoc. Biol., May 1, 2001; 69(5): 741 - 746. [Abstract] [Full Text]
|
|
|
|
|
|
M.-G. Roncarolo, M. K. Levings, and C. Traversari Differentiation of T Regulatory Cells by Immature Dendritic Cells J. Exp. Med., January 15, 2001; 193(2): f5 - f10. [Full Text] [PDF]
|
|
|
|
|
|
W. Mwangi, W. C. Brown, and G. H. Palmer Identification of Fetal Liver Tyrosine Kinase 3 (Flt3) Ligand Domain Required for Receptor Binding and Function Using Naturally Occurring Ligand Isoforms J. Immunol., December 15, 2000; 165(12): 6966 - 6974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hayday and J. L. Viney The Ins and Outs of Body Surface Immunology Science, October 6, 2000; 290(5489): 97 - 100. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
